CONTRA ACHILLION PHARM's ticker is and the CUSIP is 004CVR031. A total of 4 filers reported holding CONTRA ACHILLION PHARM in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | – | 43,420 | +100.0% | 0.00% | – |
| Q3 2021 | $0 | – | 21,710 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 21,710 | +72.6% | 0.00% | – |
| Q1 2021 | $0 | – | 12,580 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 12,580 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 12,580 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 12,580 | -39.4% | 0.00% | – |
| Q1 2020 | $0 | – | 20,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tradition Wealth Management, LLC | 4,000 | $0 | 0.00% |
| LOGAN CAPITAL MANAGEMENT INC | 20,000 | $0 | 0.00% |
| Pacer Advisors, Inc. | 6,273 | $3,000 | 0.00% |
| AMALGAMATED BANK | 12,580 | $0 | 0.00% |